Semi-Annual Consolidated Balance Sheet

JCR Pharmaceuticals Co.,Ltd. - Filing #7713976

Concept As at
2018-12-31
As at
2018-03-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
6,888,000,000 JPY
4,895,000,000 JPY
Securities
839,000,000 JPY
1,217,000,000 JPY
Other
698,000,000 JPY
592,000,000 JPY
Current assets
24,812,000,000 JPY
22,831,000,000 JPY
Non-current assets
Property, plant and equipment
10,587,000,000 JPY
10,853,000,000 JPY
Property, plant and equipment
Buildings and structures
Buildings and structures, net
4,539,000,000 JPY
4,755,000,000 JPY
Land
3,882,000,000 JPY
3,882,000,000 JPY
Construction in progress
154,000,000 JPY
JPY
Other
Other, net
2,011,000,000 JPY
2,215,000,000 JPY
Intangible assets
Intangible assets
92,000,000 JPY
112,000,000 JPY
Investments and other assets
4,030,000,000 JPY
4,600,000,000 JPY
Investments and other assets
Investment securities
2,880,000,000 JPY
3,194,000,000 JPY
Other
1,174,000,000 JPY
1,429,000,000 JPY
Allowance for doubtful accounts
-24,000,000 JPY
-22,000,000 JPY
Non-current assets
14,711,000,000 JPY
15,567,000,000 JPY
Assets
39,523,000,000 JPY
38,398,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
1,021,000,000 JPY
585,000,000 JPY
Short-term borrowings
3,530,000,000 JPY
2,893,000,000 JPY
Income taxes payable
102,000,000 JPY
887,000,000 JPY
Other
2,543,000,000 JPY
2,097,000,000 JPY
Current liabilities
7,581,000,000 JPY
7,105,000,000 JPY
Non-current liabilities
Long-term borrowings
1,950,000,000 JPY
2,500,000,000 JPY
Retirement benefit liability
683,000,000 JPY
641,000,000 JPY
Other
195,000,000 JPY
307,000,000 JPY
Non-current liabilities
3,078,000,000 JPY
3,764,000,000 JPY
Liabilities
10,659,000,000 JPY
10,870,000,000 JPY
Provision for bonuses
323,000,000 JPY
560,000,000 JPY
Provision for bonuses for directors (and other officers)
60,000,000 JPY
80,000,000 JPY
Net assets
Share capital
9,061,000,000 JPY
9,061,000,000 JPY
Shareholders' equity
Capital surplus
10,930,000,000 JPY
10,947,000,000 JPY
Retained earnings
11,503,000,000 JPY
10,469,000,000 JPY
Treasury shares
-3,956,000,000 JPY
-4,042,000,000 JPY
Shareholders' equity
27,539,000,000 JPY
26,435,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
577,000,000 JPY
462,000,000 JPY
Foreign currency translation adjustment
170,000,000 JPY
169,000,000 JPY
Remeasurements of defined benefit plans
-51,000,000 JPY
-67,000,000 JPY
Valuation and translation adjustments
695,000,000 JPY
563,000,000 JPY
Share acquisition rights
437,000,000 JPY
344,000,000 JPY
Non-controlling interests
190,000,000 JPY
185,000,000 JPY
Net assets
28,863,000,000 JPY
27,528,000,000 JPY
Liabilities and net assets
39,523,000,000 JPY
38,398,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.